Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP551408.RADo9qBT-HFfc3KmAnQIMtE2fudnJRM5I0QeQ4nuqpXHg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP551408.RADo9qBT-HFfc3KmAnQIMtE2fudnJRM5I0QeQ4nuqpXHg130_assertion type Assertion NP551408.RADo9qBT-HFfc3KmAnQIMtE2fudnJRM5I0QeQ4nuqpXHg130_head.
- NP551408.RADo9qBT-HFfc3KmAnQIMtE2fudnJRM5I0QeQ4nuqpXHg130_assertion wasGeneratedBy ECO_0000203 NP551408.RADo9qBT-HFfc3KmAnQIMtE2fudnJRM5I0QeQ4nuqpXHg130_provenance.
- NP551408.RADo9qBT-HFfc3KmAnQIMtE2fudnJRM5I0QeQ4nuqpXHg130_assertion wasDerivedFrom befree-20150227 NP551408.RADo9qBT-HFfc3KmAnQIMtE2fudnJRM5I0QeQ4nuqpXHg130_provenance.
- NP551408.RADo9qBT-HFfc3KmAnQIMtE2fudnJRM5I0QeQ4nuqpXHg130_assertion SIO_000772 17971485 NP551408.RADo9qBT-HFfc3KmAnQIMtE2fudnJRM5I0QeQ4nuqpXHg130_provenance.
- NP551408.RADo9qBT-HFfc3KmAnQIMtE2fudnJRM5I0QeQ4nuqpXHg130_assertion evidence source_evidence_literature NP551408.RADo9qBT-HFfc3KmAnQIMtE2fudnJRM5I0QeQ4nuqpXHg130_provenance.
- NP551408.RADo9qBT-HFfc3KmAnQIMtE2fudnJRM5I0QeQ4nuqpXHg130_assertion description "[Further, we identify a novel subgroup of patients with CLL with early progressive disease that appears particularly sensitive to MDM2 inhibitor treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP551408.RADo9qBT-HFfc3KmAnQIMtE2fudnJRM5I0QeQ4nuqpXHg130_provenance.